Smith & Nephew SNATS

Smith & Nephew SNATS R&D per Employee

The R&D Spending per Employee of Smith & Nephew SNATS (SNN) as of Nov 4, 2026 is 19,737.59 USD. In the previous year, R&D Spending per Employee was 19,566.46 USD — a change of 0.87% (higher).

R&D per Employee

19,737.59USD

YoY

0.87%

Last updated:

R&D Spending per Employee of Smith & Nephew SNATS is 2025 19,737.59 USD. R&D Spending per Employee of Smith & Nephew SNATS was 2024 19,566.46 USD. It decreases by 0.87% higher compared to the previous year.

The Smith & Nephew SNATS R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
14,033.09 USD
Jan 1, 2019
16,657.16 USD
Jan 1, 2020
17,512.84 USD
Jan 1, 2021
20,308.04 USD
Jan 1, 2022
19,680.55 USD
Jan 1, 2023
19,338.28 USD
Jan 1, 2024
19,566.46 USD
Jan 1, 2025
19,737.59 USD
The Smith & Nephew SNATS R&D per Employee history
YEARR&D per EmployeeYoY
19,737.59USD+0.87%
19,566.46USD+1.18%
19,338.28USD-1.74%
19,680.55USD-3.09%
20,308.04USD+15.96%
17,512.84USD+5.14%
16,657.16USD+18.70%
14,033.09USD+10.31%
12,721.05USD-3.04%
13,120.37USD+3.60%
12,664.00USD-5.53%
13,405.59USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Smith & Nephew SNATS Stock analysis

What does Smith & Nephew SNATS do? Smith & Nephew SNATS Inc operates in the medical device sector, focusing on orthopaedic implants and surgical solutions. The company generates revenue through knee and hip implant products used in joint replacement procedures, including revision surgeries. Its trauma and extremities segment offers internal and external devices for fracture stabilization and deformity correction. Sports Medicine & ENT segment sells joint repair products, arthroscopic equipment, and tissue resection devices for minimally invasive surgeries. Advanced Wound Management provides specialized wound care solutions, though specific products are not detailed in the description. The primary buyers are healthcare providers and hospitals globally, particularly in the United Kingdom, United States, and international markets. Orthopaedics and Sports Medicine & ENT segments target surgeons and orthopaedic specialists, while Advanced Wound Management serves wound care professionals. The company’s products are sold under its own brand, with no external brand names mentioned in the description. Revenue streams include direct sales of medical devices to hospitals and clinics, with no mention of subscription models or service-based fees. The company’s focus on surgical solutions and implants drives its market position, with key segments defined by product categories rather than geographic regions. No additional revenue streams like data services or digital platforms are referenced in the business description. Smith & Nephew SNATS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Smith & Nephew SNATS stock

R&D Spending per Employee of Smith & Nephew SNATS is 19,737.59 USD in 2025.

R&D Spending per Employee of Smith & Nephew SNATS changed from 19,566.46 USD to 19,737.59 USD, representing a 0.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Smith & Nephew SNATS since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Smith & Nephew SNATS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Smith & Nephew SNATS

All Key Metrics — Smith & Nephew SNATS